Literature DB >> 2013061

Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing.

B N La Du1, C F Bartels, C P Nogueira, M Arpagaus, O Lockridge.   

Abstract

1. New information identifying nucleotide alterations of human butyrylcholinesterase allows the use of more specific nomenclature for the variants commonly known as atypical, fluoride, silent, and K variant. 2. In addition to suggesting a system of trivial names and abbreviations, we provide a list of formal names that follow the guidelines of the Committee for Human Gene Nomenclature. 3. It is suggested that formal names be included in publications whenever possible.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2013061     DOI： 10.1007/bf00712801

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN： 0272-4340            Impact factor:   5.046


  43 in total

1.  On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers.

Authors:  W KALOW; N STARON
Journal:  Can J Biochem Physiol       Date:  1957-12

2.  New allele at cholinesterase locus 1.

Authors:  P J Garry; A A Dietz; T Lubrano; P C Ford; K James; H M Rubinstein
Journal:  J Med Genet       Date:  1976-02       Impact factor: 6.318

3.  Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.

Authors:  A Tunek; L A Svensson
Journal:  Drug Metab Dispos       Date:  1988 Sep-Oct       Impact factor: 3.922

4.  A common language for physical mapping of the human genome.

Authors:  M Olson; L Hood; C Cantor; D Botstein
Journal:  Science       Date:  1989-09-29       Impact factor: 47.728

5.  The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.

Authors:  J J Savarese; H H Ali; S J Basta; P B Embree; R P Scott; N Sunder; J N Weakly; W B Wastila; H A el-Sayad
Journal:  Anesthesiology       Date:  1988-05       Impact factor: 7.892

6.  Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987).

Authors:  T B Shows; P J McAlpine; C Boucheix; F S Collins; P M Conneally; J Frézal; H Gershowitz; P N Goodfellow; J G Hall; P Issitt; C A Jones; B B Knowles; M Lewis; V A McKusick; M Meisler; N E Morton; P Rubenstein; M S Schanfield; R D Schmickel; M H Skolnick; M A Spence; G R Sutherland; M Traver; N Van Cong; H F Willard
Journal:  Cytogenet Cell Genet       Date:  1987

7.  A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity.

Authors:  A Yoshida; A G Motulsky
Journal:  Am J Hum Genet       Date:  1969-09       Impact factor: 11.025

8.  A new high activity plasma cholinesterase variant.

Authors:  A Krause; A B Lane; T Jenkins
Journal:  J Med Genet       Date:  1988-10       Impact factor: 6.318

9.  Immunological comparison of the usual and atypical human serum cholinesterase phenotypes.

Authors:  H W Eckerson; A Oseroff; O Lockridge; B N La Du
Journal:  Biochem Genet       Date:  1983-02       Impact factor: 1.890

10.  Cholinesterase Newfoundland: a new succinylcholine-sensitive variant of cholinesterase at locus 1.

Authors:  N E Simpson; C R Elliott
Journal:  Am J Hum Genet       Date:  1981-05       Impact factor: 11.025
View more
  15 in total

1.  Structural and functional investigations of cholinesterases by means of affinity electrophoresis.

Authors:  P Masson
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

2.  DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.

Authors:  C F Bartels; F S Jensen; O Lockridge; A F van der Spek; H M Rubinstein; T Lubrano; B N La Du
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

Review 3.  Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review.

Authors:  Mohamed B Abou-Donia; Briana Siracuse; Natasha Gupta; Ashly Sobel Sokol
Journal:  Crit Rev Toxicol       Date:  2016-10-05       Impact factor: 5.635

4.  Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism.

Authors:  C F Bartels; T Zelinski; O Lockridge
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

5.  DNA mutations associated with the human butyrylcholinesterase J-variant.

Authors:  C F Bartels; K James; B N La Du
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

6.  Identification of two different point mutations associated with the fluoride-resistant phenotype for human butyrylcholinesterase.

Authors:  C P Nogueira; C F Bartels; M C McGuire; S Adkins; T Lubrano; H M Rubinstein; H Lightstone; A F Van der Spek; O Lockridge; B N La Du
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

7.  Comparison of cognitive functions between people with silent and wild-type butyrylcholinesterase.

Authors:  I Manoharan; A Kuznetsova; J D Fisk; R Boopathy; O Lockridge; S Darvesh
Journal:  J Neural Transm (Vienna)       Date:  2007-02-22       Impact factor: 3.850

8.  A soluble acetylcholinesterase provides chemical defense against xenobiotics in the pinewood nematode.

Authors:  Jae Soon Kang; Dae-Weon Lee; Young Ho Koh; Si Hyeock Lee
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

9.  Altered levels of acetylcholinesterase in Alzheimer plasma.

Authors:  María-Salud García-Ayllón; Iolanda Riba-Llena; Carol Serra-Basante; Jordi Alom; Rathnam Boopathy; Javier Sáez-Valero
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

10.  Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE.

Authors:  L F Neville; A Gnatt; Y Loewenstein; S Seidman; G Ehrlich; H Soreq
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.